
FDA Approves RiVive: Nasal Spray for Opioid Overdose Prevention Goes Over-the-Counter
The U.S. Food and Drug Administration recently approved RiVive, 3 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription use for the emergency treatment of known or suspected opioid …
FDA Approves RiVive: Nasal Spray for Opioid Overdose Prevention Goes Over-the-Counter Read More